175 related articles for article (PubMed ID: 18463976)
21. Analysis of FHIT gene methylation in egyptian breast cancer women: association with clinicopathological features.
Zaki SM; Abdel-Azeez HA; El Nagar MR; Metwally KA; S Ahmed MM
Asian Pac J Cancer Prev; 2015; 16(3):1235-9. PubMed ID: 25735361
[TBL] [Abstract][Full Text] [Related]
22. Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females.
Hafez MM; Al-Shabanah OA; Al-Rejaie SS; Al-Harbi NO; Hassan ZK; Alsheikh A; Al Theyab AI; Aldelemy ML; Sayed-Ahmed MM
Asian Pac J Cancer Prev; 2015; 16(2):541-9. PubMed ID: 25684485
[TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
Kozomara Z; Supic G; Krivokuca A; Magic Z; Dzodic R; Milovanovic Z; Brankovic-Magic M
J BUON; 2018; 23(3):684-691. PubMed ID: 30003738
[TBL] [Abstract][Full Text] [Related]
24. [The Methylation of p16 Gene Promoter in Carcinogenesis and Development of Breast Cancer].
Zhang YB; Lu HX; Zhang XR; Qin LJ; Dong GL; Sun N; Zhang T
Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):409-12. PubMed ID: 26121863
[TBL] [Abstract][Full Text] [Related]
25. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
[TBL] [Abstract][Full Text] [Related]
26. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
27. Aberrant gene promoter methylation of E-cadherin, p16
Burassakarn A; Pientong C; Sunthamala N; Chuerduangphui J; Vatanasapt P; Patarapadungkit N; Kongyingyoes B; Ekalaksananan T
Med Oncol; 2017 Jul; 34(7):128. PubMed ID: 28573642
[TBL] [Abstract][Full Text] [Related]
28. Very high frequency of hypermethylated genes in breast cancer metastasis to the bone, brain, and lung.
Mehrotra J; Vali M; McVeigh M; Kominsky SL; Fackler MJ; Lahti-Domenici J; Polyak K; Sacchi N; Garrett-Mayer E; Argani P; Sukumar S
Clin Cancer Res; 2004 May; 10(9):3104-9. PubMed ID: 15131050
[TBL] [Abstract][Full Text] [Related]
29. Association between p16, hMLH1 and E-cadherin promoter hypermethylation and intake of local hot salted tea and sun-dried foods in Kashmiris with gastric tumors.
Mir MR; Shabir N; Wani KA; Shaff S; Hussain I; Banday MA; Chikan NA; Bilal S; Aejaz S
Asian Pac J Cancer Prev; 2012; 13(1):181-6. PubMed ID: 22502664
[TBL] [Abstract][Full Text] [Related]
30. CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis.
Ramezani F; Salami S; Omrani MD; Maleki D
Asian Pac J Cancer Prev; 2012; 13(2):451-7. PubMed ID: 22524805
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers.
Dikshit RP; Gillio-Tos A; Brennan P; De Marco L; Fiano V; Martinez-Peñuela JM; Boffetta P; Merletti F
Cancer; 2007 Oct; 110(8):1745-51. PubMed ID: 17786935
[TBL] [Abstract][Full Text] [Related]
32. P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation.
Paredes J; Albergaria A; Oliveira JT; Jerónimo C; Milanezi F; Schmitt FC
Clin Cancer Res; 2005 Aug; 11(16):5869-77. PubMed ID: 16115928
[TBL] [Abstract][Full Text] [Related]
33. Comparison of methylation-specific polymerase chain reaction (MSP) with reverse transcriptase-polymerase chain reaction (RT-PCR) in peripheral blood of gastric cancer patients.
Koike H; Ichikawa D; Ikoma H; Otsuji E; Kitamura K; Yamagishi H
J Surg Oncol; 2004 Sep; 87(4):182-6. PubMed ID: 15334633
[TBL] [Abstract][Full Text] [Related]
34. p16 promoter hypermethylation is associated with increased breast cancer risk.
Wang L; Tang L; Xie R; Nie W; Chen L; Guan X
Mol Med Rep; 2012 Oct; 6(4):904-8. PubMed ID: 22824969
[TBL] [Abstract][Full Text] [Related]
35. DNA methylation profiles of lung tumors.
Toyooka S; Toyooka KO; Maruyama R; Virmani AK; Girard L; Miyajima K; Harada K; Ariyoshi Y; Takahashi T; Sugio K; Brambilla E; Gilcrease M; Minna JD; Gazdar AF
Mol Cancer Ther; 2001 Nov; 1(1):61-7. PubMed ID: 12467239
[TBL] [Abstract][Full Text] [Related]
36. [Demethylation of estrogen receptor gene and its re-expression in estrogen receptor-negative breast].
Wang R; Li LW; Wang RL; Fan QX; Zhao PR; Wang LX; Lu SH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):894-7. PubMed ID: 17533738
[TBL] [Abstract][Full Text] [Related]
37. p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.
Abbaszadegan MR; Moaven O; Sima HR; Ghafarzadegan K; A'rabi A; Forghani MN; Raziee HR; Mashhadinejad A; Jafarzadeh M; Esmaili-Shandiz E; Dadkhah E
World J Gastroenterol; 2008 Apr; 14(13):2055-60. PubMed ID: 18395906
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.
Huang R; Ding P; Yang F
Drug Des Devel Ther; 2015; 9():5277-85. PubMed ID: 26425077
[TBL] [Abstract][Full Text] [Related]
39. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
40. Progesterone receptor B (PRB) promoter hypermethylation in sporadic breast cancer: progesterone receptor B hypermethylation in breast cancer.
Mc Cormack O; Chung WY; Fitzpatrick P; Cooke F; Flynn B; Harrison M; Fox E; Gallagher E; McGoldrick A; Dervan PA; McCann A; Kerin MJ
Breast Cancer Res Treat; 2008 Sep; 111(1):45-53. PubMed ID: 17896177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
